Acute inflammation is a complex process that involves the release of various chemical mediators from damaged cells, immune cells, and blood vessels. These mediators help to initiate and propagate the inflammatory response. Here are some of the key chemical mediators of acute inflammation and their mechanisms of action:

1. Histamine: Histamine is a vasoactive amine that is stored in mast cells and basophils. It is released in response to tissue injury or allergic reactions. Histamine causes vasodilation, increased vascular permeability, and recruitment of immune cells to the site of injury.
2. Bradykinin: Bradykinin is a peptide that is generated from plasma proteins by the action of enzymes called kinins. It causes vasodilation, increased vascular permeability, and activation of pain receptors.
3. Prostaglandins: Prostaglandins are lipid mediators that are synthesized from arachidonic acid by the action of cyclooxygenase enzymes. They cause vasodilation, increased vascular permeability, and activation of pain receptors.
4. Leukotrienes: Leukotrienes are lipid mediators that are synthesized from arachidonic acid by the action of lipoxygenase enzymes. They cause vasodilation, increased vascular permeability, and recruitment of immune cells to the site of injury.
5. Cytokines: Cytokines are a group of signaling proteins that are released by immune cells and other cells in response to tissue injury or infection. They include interleukins, tumor necrosis factor, and interferons. Cytokines help to coordinate the immune response and promote inflammation.
6. Chemokines: Chemokines are a group of signaling proteins that are released by immune cells and other cells in response to tissue injury or infection. They help to recruit immune cells to the site of injury and promote inflammation.
7. Complement proteins: Complement proteins are a group of plasma proteins that are activated in response to tissue injury or infection. They help to promote inflammation, recruit immune cells, and destroy pathogens.

The mechanisms of action of these chemical mediators involve binding to specific receptors on target cells, such as endothelial cells, immune cells, and smooth muscle cells. This binding triggers a cascade of intracellular signaling events that lead to changes in gene expression, cell activation, and the release of additional mediators. The overall effect is to promote inflammation, recruit immune cells, and facilitate tissue repair.

1. Mucous membrane and its nerve supply:

The tongue is covered by a mucous membrane that is continuous with the mucous membrane of the floor of the mouth and the oropharynx. The mucous membrane of the tongue is divided into two regions: the anterior two-thirds and the posterior one-third. The anterior two-thirds of the tongue is covered by a stratified squamous epithelium that contains numerous papillae, which are small projections that give the tongue its rough texture. The posterior one-third of the tongue is covered by a lymphoid tissue known as the lingual tonsil.

The mucous membrane of the tongue is richly innervated by sensory fibers that are responsible for taste, touch, and temperature sensation. The anterior two-thirds of the tongue is supplied by the lingual nerve, which is a branch of the mandibular division of the trigeminal nerve (cranial nerve V). The posterior one-third of the tongue is supplied by the glossopharyngeal nerve (cranial nerve IX).

2. Muscles, movements produced by them and their nerve supply:

The tongue is composed of a group of intrinsic and extrinsic muscles that work together to produce a variety of movements. The intrinsic muscles are located entirely within the tongue and are responsible for changing the shape of the tongue. The extrinsic muscles are attached to the tongue and other structures in the head and neck, and are responsible for moving the tongue in different directions.

The intrinsic muscles of the tongue include the superior longitudinal, inferior longitudinal, transverse, and vertical muscles. These muscles are responsible for changing the shape of the tongue, such as curling, flattening, and narrowing.

The extrinsic muscles of the tongue include the genioglossus, hyoglossus, styloglossus, and palatoglossus muscles. The genioglossus muscle is the largest and most important extrinsic muscle of the tongue. It originates from the mandible and inserts into the tongue, and is responsible for protruding and retracting the tongue. The hyoglossus muscle originates from the hyoid bone and inserts into the tongue, and is responsible for depressing and retracting the tongue. The styloglossus muscle originates from the styloid process of the temporal bone and inserts into the tongue, and is responsible for elevating and retracting the tongue. The palatoglossus muscle originates from the soft palate and inserts into the tongue, and is responsible for elevating the back of the tongue.

The muscles of the tongue are supplied by the hypoglossal nerve (cranial nerve XII), which provides motor innervation to all of the intrinsic and extrinsic muscles of the tongue except for the palatoglossus muscle, which is supplied by the vagus nerve (cranial nerve X).

3. Lymphatic drainage:

The lymphatic drainage of the tongue is important for the removal of waste products and the immune response. The anterior two-thirds of the tongue drains into the submental and submandibular lymph nodes, while the posterior one-third of the tongue drains into the upper deep cervical lymph nodes.

4. Clinical anatomy:

The anatomy of the tongue is important for a variety of clinical applications, including speech therapy, dentistry, and oral surgery. Knowledge of the nerve supply to the tongue is important for diagnosing and treating conditions such as Bell’s palsy and trigeminal neuralgia. The lymphatic drainage of the tongue is important for the diagnosis and treatment of head and neck cancers. The extrinsic muscles of the tongue can be affected in conditions such as amyotrophic lateral sclerosis (ALS) and myasthenia gravis, which can lead to difficulties with speech and swallowing.

The cervical part of the sympathetic chain is a component of the sympathetic nervous system, which is responsible for the “fight or flight” response. It is located on either side of the cervical vertebrae, extending from the base of the skull to the first thoracic vertebra.

The cervical part of the sympathetic chain consists of three ganglia: the superior cervical ganglion, the middle cervical ganglion, and the inferior cervical ganglion (also known as the stellate ganglion).

1. Superior cervical ganglion:

The superior cervical ganglion is the largest of the three cervical ganglia and is located at the level of the second and third cervical vertebrae. It receives preganglionic fibers from the upper thoracic segments of the spinal cord and provides postganglionic fibers to the head and neck.

The postganglionic fibers from the superior cervical ganglion innervate the blood vessels, sweat glands, and pupillary dilator muscles of the eye. They also provide sympathetic innervation to the salivary glands, the pharynx, and the larynx.

2. Middle cervical ganglion:

The middle cervical ganglion is located at the level of the sixth cervical vertebra and is often small or absent in some individuals. It receives preganglionic fibers from the middle thoracic segments of the spinal cord and provides postganglionic fibers to the heart and lungs.

3. Inferior cervical ganglion (stellate ganglion):

The inferior cervical ganglion, also known as the stellate ganglion, is formed by the fusion of the inferior cervical ganglion and the first thoracic ganglion. It is located at the level of the seventh cervical vertebra and receives preganglionic fibers from the lower thoracic and upper lumbar segments of the spinal cord.

The postganglionic fibers from the stellate ganglion provide sympathetic innervation to the head, neck, and upper extremities. They also innervate the blood vessels, sweat glands, and piloerector muscles of the skin.

The stellate ganglion is a common site for sympathetic blockade, a procedure used to diagnose and treat certain pain conditions, such as complex regional pain syndrome and reflex sympathetic dystrophy.

In cases of firearm injury, a forensic pathologist can play a critical role in establishing the characteristics of the entry wound and determining the distance of fire. Here are some steps that a forensic pathologist might take to evaluate a smooth barrel shotgun injury to the chest:

1. External examination: The forensic pathologist will begin by examining the body externally, noting the location and characteristics of the entry wound. The wound may be irregular and larger than the diameter of the shot pellets due to the spreading of the shot pattern. The wound may also have a characteristic “abraded” or “tattooed” appearance due to the presence of gunpowder residue or other debris.
2. Measurement of the wound margins: The distance between the wound margins can provide an estimate of the distance of fire. In general, the closer the firearm is to the body, the smaller the entry wound will be. At close range (less than 3 feet), the wound margins may be abraded or seared due to the heat and pressure of the muzzle blast.
3. Collection of gunpowder residue: The presence of gunpowder residue on the skin or clothing around the entry wound can provide information about the distance of fire. Gunpowder residue is typically deposited in a radial pattern around the wound at close range (less than 3 feet), but may not be present at longer distances. The forensic pathologist may use swabs or tape lifts to collect gunpowder residue for further analysis.
4. X-ray examination: X-ray examination can be used to identify the presence and location of shot pellets and other foreign bodies in the wound track. This can help to determine the trajectory of the shot and the position of the firearm relative to the body.
5. Internal examination: The forensic pathologist will then perform an internal examination of the body, noting the extent and location of internal injuries. In a shotgun injury to the chest, the internal injuries may include damage to the lungs, heart, and major blood vessels.
6. Shot pattern analysis: Shot pattern analysis can be used to determine the distance of fire by examining the distribution of shot pellets on a target. The forensic pathologist may perform shot pattern analysis using a test target placed at a known distance from the firearm.
7. Consultation with firearms experts: In some cases, the forensic pathologist may consult with firearms experts to help determine the characteristics of the firearm and ammunition used in the injury.

1. Vitamin D resistant rickets:

Vitamin D resistant rickets, also known as hypophosphatemic rickets, is a rare inherited disorder characterized by low levels of phosphate in the blood and impaired bone mineralization. Despite adequate levels of vitamin D, patients with this condition are unable to maintain normal levels of phosphate, leading to rickets and bone deformities.

The most common cause of vitamin D resistant rickets is a mutation in the gene encoding for the renal sodium-phosphate cotransporter, which leads to decreased reabsorption of phosphate in the kidneys and subsequent hypophosphatemia. Other causes include mutations in the genes encoding for fibroblast growth factor 23 (FGF23) or the vitamin D receptor (VDR).

Treatment of vitamin D resistant rickets typically involves oral phosphate supplementation and active vitamin D analogs, such as calcitriol. In some cases, surgery may be required to correct bone deformities.

2. Chromium as a trace element:

Chromium is a trace element that is required in small amounts for normal human health. It plays a role in carbohydrate and lipid metabolism and is thought to enhance the action of insulin, a hormone that regulates blood sugar levels.

The primary dietary sources of chromium include meat, fish, poultry, and whole grains. Chromium deficiency is rare, but may occur in people with certain medical conditions, such as malabsorption syndromes or long-term use of total parenteral nutrition.

Chromium supplements are sometimes used to treat or prevent chromium deficiency, as well as to improve glucose control in people with type 2 diabetes. However, the evidence for the effectiveness of chromium supplements in these indications is limited and inconsistent.

High doses of chromium supplements can cause adverse effects, such as gastrointestinal disturbances, kidney damage, and liver dysfunction. Therefore, it is important to use chromium supplements only under the guidance of a healthcare provider.

Pharmacotherapy of gout involves the use of medications to relieve acute symptoms and prevent future attacks. The main goals of pharmacotherapy are to reduce inflammation, lower uric acid levels, and prevent joint damage.

1. Nonsteroidal anti-inflammatory drugs (NSAIDs): NSAIDs are often the first-line treatment for acute gout attacks. They work by reducing inflammation and pain. Commonly used NSAIDs include ibuprofen, naproxen, and indomethacin.
2. Colchicine: Colchicine is an alkaloid derived from the autumn crocus plant. It has been used for centuries to treat gout. Colchicine works by inhibiting the inflammatory response to uric acid crystals. It is often used in combination with NSAIDs or as an alternative for patients who cannot tolerate NSAIDs.
3. Corticosteroids: Corticosteroids are powerful anti-inflammatory drugs that can be used to treat acute gout attacks. They can be administered orally, intramuscularly, or intra-articularly. Corticosteroids are often used in patients who cannot tolerate NSAIDs or colchicine.
4. Urate-lowering therapy (ULT): ULT is used to lower uric acid levels in the blood and prevent future gout attacks. ULT drugs include xanthine oxidase inhibitors (allopurinol and febuxostat) and uricosuric agents (probenecid and sulfinpyrazone). ULT is usually started after an acute gout attack has resolved and is continued long-term to prevent future attacks.

Rationale for the use of colchicine during attack of gout:

Colchicine is often used during an acute gout attack to relieve pain and inflammation. The exact mechanism of action of colchicine is not fully understood, but it is thought to work by inhibiting the inflammatory response to uric acid crystals.

Colchicine binds to tubulin, a protein involved in the formation of microtubules, which are essential for cell division and movement. By binding to tubulin, colchicine disrupts microtubule formation and inhibits the migration of neutrophils, which are white blood cells that play a key role in the inflammatory response to uric acid crystals.

Colchicine also inhibits the release of inflammatory mediators, such as interleukin-1 beta and tumor necrosis factor-alpha, which contribute to the pain and inflammation associated with gout.

Calcium channel blockers (CCBs) are a class of drugs that block the influx of calcium ions into cells, particularly smooth muscle cells in the heart and blood vessels. By blocking calcium channels, CCBs cause relaxation of smooth muscle, leading to vasodilation and reduced cardiac workload. There are three main types of CCBs: dihydropyridines (e.g. amlodipine, nifedipine), phenylalkylamines (e.g. verapamil), and benzothiazepines (e.g. diltiazem).

Pharmacology of calcium channel blockers:

1. Mechanism of action: CCBs block the influx of calcium ions into cells by binding to L-type calcium channels in the cell membrane. This reduces the availability of calcium ions for contraction of smooth muscle cells in the heart and blood vessels, leading to vasodilation and reduced cardiac workload.
2. Pharmacokinetics: CCBs are well absorbed from the gastrointestinal tract and undergo extensive first-pass metabolism in the liver. They have variable half-lives, ranging from a few hours to several days. CCBs are highly protein-bound and are primarily eliminated by hepatic metabolism and renal excretion.
3. Indications: CCBs are used to treat a variety of cardiovascular conditions, including hypertension, angina, and certain arrhythmias. They are also used to prevent migraines and to treat Raynaud’s phenomenon.
4. Side effects: Common side effects of CCBs include headache, dizziness, flushing, and peripheral edema. More serious side effects include hypotension, bradycardia, and heart failure.

Reasons for combining beta blockers with amlodipine:

1. Complementary mechanisms of action: Beta blockers and amlodipine have complementary mechanisms of action. Beta blockers reduce cardiac output and heart rate, while amlodipine causes vasodilation and reduces peripheral resistance. This combination can lead to greater reductions in blood pressure than either drug alone.
2. Improved efficacy: Combining beta blockers with amlodipine can improve efficacy in patients with hypertension who do not respond adequately to monotherapy.
3. Reduced side effects: Combining beta blockers with amlodipine can reduce the side effects associated with high doses of either drug. For example, combining a low dose of a beta blocker with amlodipine can reduce the risk of bradycardia and heart failure associated with high doses of beta blockers.
4. Improved tolerability: Combining beta blockers with amlodipine can improve tolerability in patients who experience side effects with either drug alone. For example, combining a beta blocker with amlodipine can reduce the risk of peripheral edema associated with amlodipine.

Lung cancer, also known as carcinoma of the lung, is one of the most common and deadly types of cancer worldwide. The major risk factors associated with lung cancer include:

1. Smoking: Smoking is the single most important risk factor for lung cancer, accounting for approximately 80-90% of all cases. Both active smoking and passive smoking (exposure to secondhand smoke) increase the risk of lung cancer.
2. Exposure to occupational hazards: Exposure to certain occupational hazards, such as asbestos, radon, arsenic, and diesel exhaust, can increase the risk of lung cancer.
3. Air pollution: Exposure to outdoor air pollution, particularly fine particulate matter, has been linked to an increased risk of lung cancer.
4. Family history: A family history of lung cancer may increase the risk of developing the disease.
5. Age: The risk of lung cancer increases with age, with most cases occurring in people over the age of 65.

The gross and microscopic features of lung cancer can vary depending on the type and stage of the disease. Here are some general features:

Gross features:

1. Size and shape: Lung cancers can vary in size and shape, ranging from small, well-circumscribed nodules to large, irregular masses.
2. Location: Lung cancers can occur in any part of the lung, but are most commonly found in the upper lobes.
3. Color: Lung cancers can vary in color, ranging from white or gray to yellow or brown.

Microscopic features:

1. Cell type: Lung cancers can be classified into two main types based on the type of cells they originate from: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC is the most common type, accounting for approximately 85% of all cases.
2. Histology: The histology of lung cancer can vary depending on the type and stage of the disease. For example, NSCLC can be further classified into several subtypes, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, based on the appearance of the cancer cells under a microscope.
3. Invasion: Lung cancers can invade nearby tissues and structures, such as the pleura, chest wall, and mediastinum, and can also spread to other parts of the body through the lymphatic system or bloodstream.
4. Necrosis

The transmission of a nerve impulse through the neuromuscular junction involves several sequential events:

1. Action potential in the presynaptic neuron: The process begins with an action potential in the presynaptic neuron (the motor neuron), which travels down its axon towards the neuromuscular junction.
2. Release of neurotransmitters: When the action potential reaches the axon terminal, it triggers the release of neurotransmitters (acetylcholine) from synaptic vesicles into the synaptic cleft.
3. Binding of neurotransmitters to receptors: The neurotransmitters then bind to specific receptors (nicotinic acetylcholine receptors) on the postsynaptic membrane (the muscle fiber membrane), which triggers a series of events that lead to the generation of an action potential in the muscle fiber.
4. Generation of an action potential in the muscle fiber: The binding of neurotransmitters to receptors causes the opening of ion channels in the muscle fiber membrane, which allows an influx of positively charged ions (sodium and potassium) into the muscle fiber. This depolarizes the muscle fiber membrane, triggering an action potential that propagates along the muscle fiber.
5. Contraction of the muscle fiber: The action potential in the muscle fiber triggers the release of calcium ions from the sarcoplasmic reticulum (a specialized type of endoplasmic reticulum found in muscle fibers), which initiates the process of muscle contraction.
6. Termination of the signal: The neurotransmitters are quickly removed from the synaptic cleft by enzymes (acetylcholinesterase) that break them down, or by reuptake into the presynaptic neuron. This terminates the signal and allows the muscle fiber to relax.

1. Location: The stomach is a muscular, hollow organ located in the upper left part of the abdominal cavity, just below the diaphragm. It lies between the esophagus and the small intestine and is connected to these structures by the cardia and the pylorus, respectively.
2. External features: The stomach has several external features, including:

a. Greater curvature: This is the longer, convex border of the stomach that runs from the cardia to the pylorus.

b. Lesser curvature: This is the shorter, concave border of the stomach that runs from the cardia to the pylorus.

c. Fundus: This is the upper, dome-shaped portion of the stomach that lies above the level of the cardia.

d. Body: This is the large, central portion of the stomach that lies between the fundus and the pylorus.

e. Antrum: This is the lower, tapering portion of the stomach that lies just above the pylorus.

3. Arterial supply: The stomach receives its blood supply from several branches of the celiac trunk, including:

a. Left gastric artery: This artery supplies the lesser curvature and the cardia of the stomach.

b. Right gastric artery: This artery supplies the pylorus and the lower part of the lesser curvature.

c. Left gastroepiploic artery: This artery supplies the greater curvature and the fundus of the stomach.

d. Right gastroepiploic artery: This artery supplies the greater curvature and the antrum of the stomach.

e. Short gastric arteries: These arteries supply the fundus and the upper part of the greater curvature.

4. Clinical anatomy: Understanding the anatomy of the stomach is important for the diagnosis and treatment of various conditions that can affect the organ, such as peptic ulcers, gastritis, and gastric cancer. For example:

a. Gastric perforation: A perforation of the stomach wall can occur due to various causes, such as a peptic ulcer or trauma. This can lead to leakage of gastric contents into the abdominal cavity, which can be life-threatening.

b. Gastric outlet obstruction: This is a blockage of the pylorus that prevents the stomach from emptying properly. This can be caused by various conditions, such as a peptic ulcer, gastric cancer, or inflammation.

c. Gastric bypass surgery: This is a surgical procedure that’s used to treat obesity. It involves creating a small pouch from the upper part of the stomach and connecting it directly to the small intestine, bypassing the rest of the stomach and the first part of the small intestine.

d. Gastric cancer: This is a malignant tumor that can develop in any part of the stomach. It’s more common in older adults and is often associated with factors such as smoking, a diet high in salt and processed meats, and infection with Helicobacter pylori bacteria.